NEW YORK, January 4, 2018 /PRNewswire/ --
According to a report by Ameri Research Inc., the global legal cannabis market was valued at $14.3
billion in 2016 and is forecast to grow at a CAGR of 21.1% between 2017 to 2024, culminating to $63.5 billion by 2024. The market is going through a period of strong growth thanks to increasing legalization
and decriminalization of cannabis products across North America and Europe. The report indicates that due to the complex regulatory structure at state and federal level, the
full potential of the market is not yet realized. Data published by Arcview Market Research forecasts that growth of the legal
cannabis industry will reaccelerate beginning 2018, as adult use sales ramp up in Canada,
California, and Massachusetts along with medical sales
in Florida. Marijuana Company of America, Inc. (OTC: MCOA), Global Hemp Group, Inc. (OTC: GBHPF), Lexaria Bioscience
Corp. (OTC: LXRP), OWC Pharmaceutical Research Corp. (OTC: OWCP), Cannabis Science, Inc. (OTC: CBIS)
In states like California for example, where new recreational cannabis laws went into effect
on January 1st, 2018, analysts are projecting an increase in sales of Cannabis. New Frontier Data CEO Giadha Aguirre De
Carcer, explained, "California offers the perfect example of why it is so important to
understand trends in consumer behavior. The state's legal (cannabis) industry is forecast to grow from $2.8 billion in 2017 to $5.6 billion in 2020. That spending will be increasingly
directed at products and retailers who understand and serve the market's evolving tastes and preferences. The market is changing,
and the most successful operators will be those who adapt most quickly to the change."
Marijuana Company of America, Inc. (OTC: MCOA) yesterday announced, its 2017 year-end review to its valued shareholders
and interested parties.
Donald Steinberg, CEO of MCOA, said: "I am the founder of multiple startups, including
Medical Marijuana Inc., which has a market cap of over 300 million dollars. I am aware of the
challenges and opportunities these endeavors present, and the need for a strong foundation to build upon. Having experience in
the structuring, development and operations of large global marketing companies in various industries, I believe Marijuana
Company of America and its subsidiary hempSMART are poised to deliver significant value to our shareholders based on the
foundations and accomplishments made in the past year.
The Company has fulfilled its promise to its shareholders by becoming an audited and fully transparent reporting company with
the Securities and Exchange Commission. We are participating in the cannabis space with our leasing operation in
Washington. The hempSMART team has developed a line of products that can be viewed at http://www.hempsmart.com. We completed joint hemp trials in New Brunswick, Canada with Global Hemp Group, Inc. in 2017, and we expect to be starting commercial
production in Spring 2018. There are a number of other projects we are completing due diligence on. I am thankful to the teams at
MCOA and hempSMART for their accomplishments and due diligence in working through these various projects. We will continue
to build upon the diligent work of the past year as we continue to move forward and execute our business plan."
The Company's wholly owned subsidiary, hempSMART, Inc., distributes industrial hemp based CBD wellness products
via network marketing. In September 2017, the Company completely revamped its website and network
marketing platform to provide customers and affiliates with the necessary tools needed to become successful in the expanding
$1.9 Trillion Wellness Industry. The Company has successfully filed a patent application with the
U.S Patent and Trademark Office for full patent protection on its proprietary CBD formulation: "hempSMART™ Brain." Also in
2017, hempSMART released two new products: "hempSMART™ Full Spectrum Drops" (Orange, Mint, Lemon, and Strawberry) and
"hempSMART™ Pain Capsules." Several more products are in development and the Company anticipates their release in Q1
2018.
In Q3 2017, MCOA and Global Hemp Group, Inc. (CSE: GHG) (OTC: GBHPF) entered into a joint venture partnership to develop
commercial hemp production and processing in New Brunswick, Canada. MCOA and GHG have now
completed the first phase of hemp trials, receiving research support from the Collége Communautaire du Nouveau Brunswick (CCNB).
MCOA is granted a Right of First Refusal as the primary recipient of any raw materials produced from the project, which we
expect will harvest its first commercial crop of 125 acres in Q4 2018.
In July 2017, MCOA completed an investment of $250,000 into
MoneyTrac Technology, Inc. ("MTT"), a subsidiary of Global Payout, Inc. (OTC: GOHE) in exchange for 15% equity position in the
company, to help establish and market MTT as an alternative banking solution for the Cannabis industry. MTT currently has the
ability to integrate and streamline electronic payment processing such as E-wallet, mobile applications, debit cards, and credit
cards. Currently, MoneyTrac Technology has strategic partnerships with top cannabis services such as GreenRush, BlazeNow, High
Grade Management Group, and PotSaver, which was a majority acquisition last October."
Global Hemp Group, Inc. (OTC: GBHPF) is focused on the production and processing of hemp and cannabis, and
collaboration with companies that will enable GHG to develop and implement the Hemp Agro-Industrial Zone concept. On October 10, 2017, the company and Marijuana Company of America, Inc. announced they have jointly entered into a
letter of intent with Space Cowboys, Inc. for the purposes of forming a joint venture. Space Cowboys is an existing fully
licensed and compliant hemp derived cannabinoid producer in Colorado. Space Cowboys is in its
fourth year of operation and is in full compliance with Colorado state law and the Colorado
Department of Agriculture. The business consists of both indoor and outdoor cultivation of high CBD hemp on properties in
Longmont and Loveland, Colorado. Space Cowboys current hemp
crops will be harvested in the latter part of October and prepared for extraction of the high value cannabinoids.
Lexaria Bioscience Corp. (OTCQB: LXRP) is a research-driven company that has developed and out-licenses its disruptive
and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher
effectiveness of ingestible drugs and other beneficial molecules. On December 13, 2017, the company
announced the United States Patent and Trademark Office ("USPTO") has granted patent number 9,839,612 B2 for the use of
DehydraTECHTM technology as a delivery platform for a wide variety of Active Pharmaceutical Ingredients including all
cannabinoids including THC; fat soluble vitamins; non-steroidal anti-inflammatory pain medications; and nicotine. Lexaria also
continues to advance all of its additional patent applications in various countries as it levers patent success in the
USA. For example, some of the Company's patent applications have recently entered the active
patent investigation phase in China, the European Union, and in Canada.
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd.,
conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including
multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. On December 21, 2017, the company
received a new permit from the Israel Medical Cannabis Agency to proceed with the safety study of their oral disintegrating
tablet. The study protocol will be submitted to the Institutional Review Board at a leading Israeli academic hospital in the
coming weeks. The study is scheduled to start in Q2 2018. The technology behind the Tablet is protected and provides for the
ingestion of virtually any dosage of medical cannabis with a sublingual delivery mechanism, whereby the compounds are absorbed
directly into the patient's blood through the oral epithelial tissue. The Tablet also enables physicians to safely and accurately
gauge and monitor the dosage and treatment of each individual patient, something that is essentially impossible to do for
patients who administer cannabis by smoking.
Cannabis Science, Inc. (OTC: CBIS) takes advantage of its unique understanding of metabolic processes to provide novel
treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. On
December 28, 2017, the company announced that its expansion plans are progressing rapidly as the
final negotiations have been completed for the third medical marijuana dispensary in California.
The Company is preparing the final documents now to complete integration of its third medical marijuana operations for the
California market opening.
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. Financialbuzz.com has not been compensated directly by any of the companies mentioned here in
this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information
posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality
and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not
offer any personal opinions or bias commentary as we purely incorporate public market information along with financial and
corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial
newswire and media platform. For this release, FinancialBuzz.com has been compensated four thousand
dollars for financial news dissemination and pr services by meridian ventures for marijuana company of america inc. Our
fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a
combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance
is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or
cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the
editorial or Site or continue to post information about any companies the information contained herein is not intended to be used
as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information
contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are
not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles,
quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full
responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own
investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any
pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the
content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular
security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided
by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is
suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult
with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to
the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information
is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer,
disclosure and Terms of Use, please visit: http://www.financialbuzz.com.
For further information:
Media Contact: info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com